Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lankester

Showing results (1-10 of 207) with videos related to

Pageof 21
Sort By:
Pediatric Clinics of North America|February 5, 2008
Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology?Terry J Fry, Arjan C Lankester
Hematology/Oncology Clinics of North America|February 2, 2010
Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology?Terry J Fry, Arjan C Lankester
Molecular Immunology|June 1, 1996
Compartmentalization of B-cell antigen receptor functionsA C Lankester, R A van Lier
Journal of the Royal Army Medical Corps|September 9, 2017
Do air-gaps behind soft body armour affect protection?Lee Tilsley, D J Carr, C Lankester, et al.
Journal of the Royal Army Medical Corps|March 4, 2016
Angled shots onto body armour using 9 mm ammunition: the effect on potential blunt injuryAlison Lyall, D J Carr, C Lankester, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 19, 2003
[From gene to disease; CD40 ligand deficiency as the cause of X-linked hyper-IgM-syndrome]M Groeneweg, A C Lankester, R G M Bredius
Oncoimmunology|June 22, 2012
Immunotherapy: Is it different for sarcomas?Anne-Marie Cleton-Jansen, Emilie P Buddingh, Arjan C Lankester
Pediatric Clinics of North America|March 24, 2010
Immunotherapy in the context of hematopoietic stem cell transplantation: the emerging role of natural killer cells and mesenchymal stromal cellsArjan C Lankester, Lynne M Ball, Peter Lang, et al.
The Journal of Biological Chemistry|September 1, 1995
Hematopoietic cell phosphatase is recruited to CD22 following B cell antigen receptor ligationA C Lankester, G M van Schijndel, R A van Lier
Frontiers in Immunology|July 23, 2016
Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell PopulationsJanine E Melsen, Gertjan Lugthart, Arjan C Lankester, et al.
Pageof 21

Showing results (1-10 of 207) with videos related to

Sort By:
Pageof 21
Pediatric Clinics of North America|February 5, 2008
Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology?Terry J Fry, Arjan C Lankester
Hematology/Oncology Clinics of North America|February 2, 2010
Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology?Terry J Fry, Arjan C Lankester
Molecular Immunology|June 1, 1996
Compartmentalization of B-cell antigen receptor functionsA C Lankester, R A van Lier
Journal of the Royal Army Medical Corps|September 9, 2017
Do air-gaps behind soft body armour affect protection?Lee Tilsley, D J Carr, C Lankester, et al.
Journal of the Royal Army Medical Corps|March 4, 2016
Angled shots onto body armour using 9 mm ammunition: the effect on potential blunt injuryAlison Lyall, D J Carr, C Lankester, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 19, 2003
[From gene to disease; CD40 ligand deficiency as the cause of X-linked hyper-IgM-syndrome]M Groeneweg, A C Lankester, R G M Bredius
Oncoimmunology|June 22, 2012
Immunotherapy: Is it different for sarcomas?Anne-Marie Cleton-Jansen, Emilie P Buddingh, Arjan C Lankester
Pediatric Clinics of North America|March 24, 2010
Immunotherapy in the context of hematopoietic stem cell transplantation: the emerging role of natural killer cells and mesenchymal stromal cellsArjan C Lankester, Lynne M Ball, Peter Lang, et al.
The Journal of Biological Chemistry|September 1, 1995
Hematopoietic cell phosphatase is recruited to CD22 following B cell antigen receptor ligationA C Lankester, G M van Schijndel, R A van Lier
Frontiers in Immunology|July 23, 2016
Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell PopulationsJanine E Melsen, Gertjan Lugthart, Arjan C Lankester, et al.
Pageof 21